Abstract
DNA virus vectors generally are less likely than retrovirus vectors to require host cell proliferation in order for vector DNA to be expressed [ 1 ]. This feature may expand their utility in post-mitotic cells such as cardiac myocytes. Among DNA virus vectors, adenovirus (Ad) and adeno-associated virus type 2 (AAV) have been most thoroughly studied. The natural history of human AAV infection has not been studied as completely as Ad infection, but AAV-based vectors may have advantages for certain gene therapy applications, due to their persistence and relatively low immunogenicity. AAV-based vectors may not share all of the properties of wild- type AAV, however, and this may have implications for the use of AAV vectors in humans. A thorough understanding of AAV biology is necessary in order to develop this vector system for therapeutic applications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Flotte TR, Afione SA, Zeitlin PL: Adeno-associated virus vector gene expression occurs in non dividing cells in the absence of vector DNA integration. Am Journ Resp Cell Mol Biol 1994; 11:517 521.
Atchison RW, Casto BC, Hammon WM: Adenovirus-associated defective virus particles. Science 1965; 149:754–756.
Siegl G, Bates RC, Berns KI, et al.: Characteristics and taxonomy of parvoviridae. Intervirology 1985; 23:61–73.
Blacklow NR: Adeno-associated viruses of humans. In Parvoviruses and Human Disease (Pattison J, ed.) CRC Press 1988, Boca Raton FL, pp. 165–174.
Blacklow NR, Hoggan MD, Kapikian AZ, Austin JB, and Rowe WP: Epidemiology of adeno associated virus infection in a nursery population. Amer J Epidem 1971; 94:359–366.
Bantel-Schaal U, zurHausen H: Characterization of the DNA of a defective human parvovirus isolated from a genital site. Virology 1984;134:52–63.
Hoggan MD, Thomas GF, Johnson FB: Continuous carriage of adeno-associated virus genome in cell culture in the absence of helper adenovirus. In Proceedings of 4th LePetit Colloquium, Cocoyac, Mexico, North-Holland 1972, Amsterdam, pp. 243–253.
Cheung AMK, Hoggan MD, Hauswirth WW, Berns DI: Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells. J Virol 1980; 33:739–748.
Mayor HD, Drake S, Stahmann J, Mumford DM: Antibodies to adeno-associated satellite virus and herpes simplex in sera from cancer patients and normal adults. Amer Journ Obstret Gynec 1976; 126:100.
Hermonat PL: The adeno-associated virus Rep78 gene inhibits cellular transformation by bovine papilloma virus. Virology 1989; 172:253–261.
Labow MA, Graf LH, and Berns KI: Adeno-associated virus gene expression inhibits cellular ransformation by heterologous genes. Mol CellBiol 1987; 7:1320–1325.
Khlief SN, Myers T, Carter BJ, Trempe JP: Inhibition of cellular transformation by the adeno associated virus rep gene. Virology 1991; 181:738–741.
Cukor G, Blacklow NR, Kibrick S, and Swan IC: Effect of adeno-associated virus on cancer expression by Herpesvirus-transformed cells. J Natl Cane Inst 1975; 55:957–959.
Hermonat PL: Inhibition of H-ras expression by the adeno-associated virus rep78 transformation suppressor product. Carter Res 1991; 51:3373–3377.
Ostrove JM, Duckworth DH, Berns KI: Inhibition of adenovirus-transformed cell oncogenicity by adeno-associated virus. Virology 1981; 113:521-533.
Kirschstein RL, Smith KO, Peters EA: Inhibition of adenovirus 12 oncogenicity by adeno associated virus. Proc Soc Exp Biol Med 1968; 128:670–673.
Mayor HD, Houlditch GS, Mumford DM: Influence of adeno-associated virus on adenovirusnduced tumors in hamsters. Nature 1973; 241:44–46.
De La Maza LM, Carter BJ: Inhibition of adenovirus oncogenicity in hamsters by adeno associated virus DNA. J Natl Canc Inst 1981; 67:1323–1326.
Berns KI: Parvoviridae and their replication in Fields Virology, 2nd ed. ( Fields BN & Knipe DM, eds.) Raven Press 1990, New York, NY. Vol 2, pp. 1743–1763.
Samulski RJ, Berns KI, Tan M, Muzyczka N: Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sci USA 1982; 79:2077–2081.
Laughlin CA, Tratschin JD, Coon H, Carter BJ: Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene 1983; 23:65–73.
Carter BJ: The growth cycle of adeno-associated virus. In Handbook of Parvoviruses (Tjissen P, ed.) CRC Press 1990, Boca Raton, FL. Vol I, pp. 155–168.
Carter BJ, Mendelson E, Trempe JP: AAV DNA replication, integration, and genetics. In Handbook of Parvoviruses (Tjissen P, ed.) CRC Press 1990, Boca Raton, FL. Vol I, pp. 169–226.
Berns, KI: Parvoviridae and their replication. In Virology (Fields BN, Knipe DM, et al., eds.) Raven Press 1990, New York, NY. pp. 1743–1764.
Srivistava A, Lusby EW, Berns KI: Nucleotide sequence and organization of the adeno associated virus 2 genome. J Virol 1983; 45:555–564.
Flotte TR, Afione SA, Solow R, et al.: Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J Biol Chem 1993; 268:3781 3790.
Tratschin JD, Miller IL, Carter BJ: Genetic analysis of adeno-associated virus: Properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function. J Virol 1984; 51:611–619.
Mendelson E, Trempe JP, Carter BJ: Identification of the trans-acting rep proteins of adeno associated virus using antibodies to a synthetic polypeptide. J Virol 1986; 60:823–832.
Snyder RO, Samulski RJ, Muzyczka N: In vitro resolution of covalently joined AAV chromosome ends. Cell 1990; 60:105–113.
Trempe JP & Carter BJ: Alternate mRNA splicing is required for synthesis of adeno-associated virus VP1 capsid protein. J Virol 1988; 62:3356–3363.
Yakinoglu AO, Heilbronn R, Bunkle A, Schlehofer JR, zurHausen H: DNA amplification of adeno-associated virus as a response to cellular genotoxic stress. Canc Res 1988; 48:3123–3125.
Handa H, Shiroki K, Shimojo H: Establishment and characterization of KB cell lines latently infected with adeno-associated virus type 1. Virol 1977; 82:84–92.
Samulski RJ, Zhu X, Xiao X, et al.: Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO Journ 1991; 10:3941–3950.
Kotin RM, Menninger JC, Ward DC, Berns KI: Mapping and direct visualization of a region specific viral DNA integration site on chromosome 19q13-qter. Genomics 1991; 10:831–834.
Kotin RM, Siniscalo M, Samulski RJ, et al.: Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 1990; 87:221–2215.
Kotin RM, Linden RM, Berns KI: Characterization of a preferred site on chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO Journ 1992; 11:5071–5078.
Samulski RJ: Adeno-associated virus: integration at a specific chromosomal locus. Curr Opin Biotech 1993; 3:74–80.
Giraud C, Winocour E, Berns KI: Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence. Proc Natl Acad Sci USA 1994; 91:10039–10043.
Weitzmann MD, Kyöstiö SRM, Kotin RM, et al.: Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc Natl Acad Sci USA 1994; 91:5808–5812.
Carter B: Adeno-associated virus vectors. Curr Opin Biotech 1992; 3:533–539.
Hermonat PL, Muzyczka N: Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc. Natl. Acad. Sci. USA 1984; 81:6466–6470.
Tratschin J-D, Miller IL, Carter BJ: A human parvovirus, adeno-associated virus, as a eucaryotic vector: Transient expression and encapsidation of the procaryotic gene for chloramphenicol acetyltransferase. J Virol 1984; 51:611–619.
Tratschin J-D, Miller IL, Smith MG, et al.: Adeno-associated virus vector for high-frequency integration, expression and rescue of genes in mammalian cells. Mol. Cell Biol. 1985; 5:3251–3260.
Samulski RJ, Chang L-S, Shenk T: Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression. J Virol 1989; 63:3822–3828.
Flotte TR, Barrazza-Ortiz X, Solow R, et al.: An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction. Gene Ther 1995; 2:29–37.
Flotte TR, Solow R, Owens RA, et al.: Gene expression from adeno-associated virus vectors in airway epithelial cells. Amer J Resp Cell Mol Biol 1992; 7:349–356.
Beaton A, Palumbo P, Berns KI: Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein. J Virol 1989; 63:4450–4
Tratschin JD, Tal J, Carter BJ: Negative and positive regulation in trans of gene expression from adeno-associated virus vectors in mammalian cells by a viral rep gene product. Mol Cell Biol 1986; 6:2884–2894.
Podsakoff G, Wong KK, Chaterjee S: Efficient gene transfer into nondividing cells by adeno associated virus-based vectors. J Virol 1994; 68:5656–5666.
Russell DW, Miller AD, Alexander IE: Adeno-associated virus vectors preferentially transduce cells in S phase. Proc Natl Acad Sci USA 1994; 91:8915–8919.
Flotte TR, Afione SA, Conrad C, et al.: Stable in vivo expession of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci USA 1993; 90:10613–10617.
Kaplitt MG, Leone P, Samulski RJ, et al.: Long-term gene expression and phenotypic correction using adeno-associated vectorsin the mammalian brain. Nature Genet 1994; 8:148–154.
Kearns WG, Afione S, Fulmer SB, et al.: Recombinant AAV vectors demonstrate episomal expression in immortalized human bronchial epithelial cells, (abstract) Presented at American Society of Human Genetics Meeting 1994.
Conrad C, Afione S, Guggino WB, et al.: Administration of AAV-CFTR vectors to the airway epithelium of non-human primates is safe and efficacious. Amer J Resp Crit Care Med 1994; 149:A236 (abst).
Grossman Z, Mendelson E, Brok-Simoni F, et al.: Detection of adeno-associated virus type 2 in human peripheral blood. J Gen Virol 1992; 73:961–966.
Chatterjee S, Johnson PR, Wong KK: Dual-target inhibition of HIV-1 by means of an adeno associated virus antisense vector. Science 1992; 258:1485–1488.
Walsh CE, Liu JM, Xiao X, et al.: Regulated high level expression of a human g-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc Natl Acad Sci USA 1992; 89:7257–7261.
Ponnazhagan S, Nallari ML, Srivastava A: Suppression of human a-globin gene expression mediated by recombinant adeno-associated virus 2-based antisense vectors. J Exp Med 1994; 179:733–738.
Miller JL, Donahue RE, Sellers SE, Samulski RJ, Young NS, Neinhuis AW: Recombinant adeno-associated virus (rAAV)-mediated expression of a human g-globin gene in human progenitor derived erythroid cells. Proc Natl Acad Sci USA 1994; 91:10183–10187.
Zhou SZ, Broxmeyer H, Cooper S, et al.: Adeno-associated virus 2-mediated gene transfer in murine hematopoietic progenitor cells. Exper Hemat 1993; 21:928–933.
Goodman S, Xiao X, Donahue RE, et al.: Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 1994; 84:1492–1500.
Egan M, Flotte T, Afione S, et al.: Defective regulation of outwardly rectifying C1 channels by protein kinase A corrected by insertion of CFTR. Nature 1992; 358:581–584.
Schwiebert EM, Flotte T, Cutting GR, et al.: Both CFTR and outwardly rectifying chloride channels contribute to cAMP-stimulated whole cell chloride currents. Amer J Physiol 1994; 266 (Cell Physiol 35):C1464–C1477.
Flotte TR: Prospects for virus-based gene therapy for cystic fibrosis. J. Bioenerg Biomembr 1993; 25:37–42.
Wei J-F, Wei F-S, Samulski RJ, Barranger JA: Expression of the human glucocerebrosidase and arylsulfatase A genes in murine and patient primary fibroblasts transduced by an adeno-associated virus vector. Gene Ther 1994; 1:261–268.
Epstein SE, Speir E, Unger EF, Guzman RJ, and Finkel T: (1994) The basis of molecular strategies for treating coronary restenosis after angioplasty. J.Am.Coll.Cardiol. 23:1278–1288
Bonnerot C, Rocancourt D, Briand P, Grimber G, Nicolas, J-F: A β-galactosidase hybrid protein targeted to nuclei as a marker for developmental studies. Proc. Natl. Acad. Sci. USA 1987 84:6795 6799.
Kourtis AP, Deyesu EE, Hruban RH, Byrne BJ: Cardiac gene therapy with adeno-associated virus as a means of achieving graft-specific immunosuppression (1994) Amer Soc. Path., in press.
Hamburger V, Hamilton HL: A series of normal stages in the development of the chick embryo J. Morph. 1951 88:49–92.
Post LE, Mackem S., Roizman B: Regulation of alpha genes of herpes simplex virus: expression of chimeric genes produced by fusion of thymidine kinase with alpha gene products. Cell 1981 24:555–565.
Spaete RR, Frankel N: The Herpes Simplex Virus Amplicon: Analysis of CIS-acting Functions. Proc. Nat. Acad. Sci. USA 1985; 82:694–698.
Sears AE, Halliburton IW, Meignier B, Silver S, Roysman B: Herpes Simplex Virus I Mutant Deleted in the α-22 Gene: Growth and Gene Expression with Permissive and Restrictive Cells in Establishment of Latency in Mice. Journal of Virology 1985; 55:338–346.
Hoess RH, Abremski K: in Nucleic Acids and Molecular Biology (F Eckstein and DMJ Lily, editors), Volume 4, page 99, Springer-Verlag, Berlin and Heidelberg, 1990
Bums WH: personal communication, 1994
Sauer B: Manipulation of Transgenes by Site-Specific Recombination: Use of Cree Recombinase. Methods in Enzymology, Volume 225, page 890–900.
Palella TD, Hydaka Y, Silverman LJ, Levine M, Glorioso JC, Kelly WN: Expression of Human HPRT mRNA in Brains of Mice Infected with a Recombinant Herpes Simplex Virus-I Vector. Gene 1989; 80:137–144.
Fink DJ, Stemburg LR, Weber PC, Mott M, Goens WF, Glorioso JC: In vivo Expression of β galactosidase in Hippocampal Neurons by HSV-mediated Gene Transfer. Human Gene Therapy 1992; 3:11–19.
Glorioso JC, Goins WF, Fink DJ: Herpes simplex virus-based vectors. Seminars in Virology 1992 3:265–276
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Flotte, T.R., Afione, S.A., Byrne, B.J., Helen, B. (1997). Adeno-Associated Virus and Other New DNA Virus Vectors. In: March, K.L. (eds) Gene Transfer in the Cardiovascular System. Developments in Cardiovascular Medicine, vol 189. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6277-1_3
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6277-1_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7881-5
Online ISBN: 978-1-4615-6277-1
eBook Packages: Springer Book Archive